10 Einträge gefunden

1. High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

   1. Heumann, Asmus
   2. Heinemann, Nina
   3. Hube-Magg, Claudia
   4. Lang, Dagmar S
   5. Grupp, Katharina
   6. Kluth, Martina
   7. Minner, Sarah

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
2. Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion

   1. Grupp, Katharina
   2. Roettger, Laura
   3. Kluth, Martina
   4. Hube-Magg, Claudia
   5. Simon, Ronald
   6. Lebok, Patrick
   7. Minner, Sarah

   2015 - Forschungsinformationssystem des UKE
3. NY-ESO-1 expression is tightly linked to TMPRSS2-ERG fusion in prostate cancer

   1. Grupp, Katharina
   2. Ospina-Klinck, Daniel
   3. Tsourlakis, Maria Christina
   4. Koop, Christina
   5. Wilczak, Waldemar
   6. Adam, Meike
   7. Simon, Ronald

   2014 - Forschungsinformationssystem des UKE
4. βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion

   1. Tsourlakis, Maria C
   2. Weigand, Philipp
   3. Grupp, Katharina
   4. Kluth, Martina
   5. Steurer, Stefan
   6. Schlomm, Thorsten
   7. Graefen, Markus

   2014 - Forschungsinformationssystem des UKE
5. Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer

   1. Kluth, Martina
   2. Harasimowicz, Silvia
   3. Burkhardt, Lia
   4. Grupp, Katharina
   5. Krohn, Antje
   6. Prien, Kristina
   7. Gjoni, Jovisa

   2014 - Forschungsinformationssystem des UKE
6. The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression

   1. Grupp, Katharina
   2. Boumesli, Rebecca
   3. Tsourlakis, Maria Christina
   4. Koop, Christina
   5. Wilczak, Waldemar
   6. Adam, Meike
   7. Sauter, Guido

   2014 - Forschungsinformationssystem des UKE
7. High mitochondria content is associated with prostate cancer disease progression

   1. Grupp, Katharina
   2. Jedrzejewska, Karolina
   3. Tsourlakis, Maria Christina
   4. Koop, Christina
   5. Wilczak, Waldemar
   6. Adam, Meike
   7. Quaas, Alexander

   2013 - Forschungsinformationssystem des UKE - frei zugänglich
8. High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers

   1. Grupp, Katharina
   2. Sanader, Stella
   3. Sirma, Hüseyin
   4. Simon, Ronald
   5. Koop, Christina
   6. Prien, Kristina
   7. Hube-Magg, Claudia

   2013 - Forschungsinformationssystem des UKE - frei zugänglich
9. Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy

   1. Grupp, Katharina
   2. Höhne, Thorsten Simon
   3. Prien, Kristina
   4. Hube-Magg, Claudia
   5. Tsourlakis, Maria Christina
   6. Sirma, Hüseyin
   7. Pham, Taher

   2013 - Forschungsinformationssystem des UKE
10. Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers

    1. Krohn, Antje
    2. Seidel, Annemarie
    3. Burkhardt, Lia
    4. Bachmann, Frederik
    5. Mader, Malte
    6. Grupp, Katharina
    7. Eichenauer, Till

    2013 - Forschungsinformationssystem des UKE